Thrombectomy Clinical Trials

23 recruitingLast updated: May 13, 2026

There are 23 actively recruiting thrombectomy clinical trials across 7 countries. Studies span Not Applicable, Phase 2. Top locations include Tianjin, Tianjin Municipality, China, Xi'an, Shaanxi, China, Shanghai, China. Updated daily from ClinicalTrials.gov.


Thrombectomy Trials at a Glance

23 actively recruiting trials for thrombectomy are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 13 trials, with the heaviest enrollment activity in Tianjin, Xi'an, and Shanghai. Lead sponsors running thrombectomy studies include Tianjin Huanhu Hospital, The First Affiliated Hospital of University of Science and Technology of China, and Cukurova University.

Browse thrombectomy trials by phase

Treatments under study

About Thrombectomy Clinical Trials

Looking for clinical trials for Thrombectomy? There are currently 13 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Thrombectomy trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Thrombectomy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 23 trials

Recruiting

Michigan Initial Experience Using Tigertriever for Thrombectomy

ThrombectomyIschemic StrokeBlood Clot
Henry Ford Health System150 enrolled1 locationNCT07363525
Recruiting
Not Applicable

Mode of Sedation During Endovascular Treatment of Vertebrobasilar Stroke

Stroke Thrombectomy
University Hospital Heidelberg128 enrolled1 locationNCT05525325
Recruiting
Not Applicable

Endovascular Therapy Versus Best Medical Treatment for Acute Large Vessel Occlusion Stroke With Low NIHSS

Mild Neurocognitive DisorderThrombectomyAcute Ischemic Stroke
First Affiliated Hospital of Wannan Medical College264 enrolled1 locationNCT06143488
Recruiting

Investigation of Brain Blood Flow Changes in Acute Ischemic Stroke Patients After Successful Endovascular Thrombectomy

ThrombectomyAcute Cerebrovascular AccidentNo-Reflow Phenomenon+1 more
University of Zurich100 enrolled1 locationNCT07534319
Recruiting
Phase 2

Intra-arterial Methylprednisolone After Endovascular Thrombectomy

ThrombectomyIschemia StrokeLarge Vessel Occlusion
Tang-Du Hospital210 enrolled1 locationNCT07516522
Recruiting

IMMunological resPonse Assessment afteR Acute iSchemic Stroke Treated With Endovascular Therapy (IMPRESS)

ThrombectomyIschemic Stroke
Fondation Ophtalmologique Adolphe de Rothschild1,200 enrolled1 locationNCT04663399
Recruiting
Not Applicable

Effects of Transcranial Magnetic Stimulation After Endovascular Treatment for Acute Ischemic Stroke

Ischemic Stroke, AcuteEndovascular Thrombectomy
Xijing Hospital60 enrolled1 locationNCT06639360
Recruiting
Phase 2

CO2 Modulation in Endovascular Thrombectomy for Acute Ischemic Stroke

ThrombectomyIschemic Stroke, AcuteCerebrovascular Circulation+2 more
University Hospital, Clermont-Ferrand50 enrolled1 locationNCT05051397
Recruiting
Not Applicable

Intra-arterial Neuroprotective Strategy for Ischemic STroke Patients With Endovascular Therapy (INSIST-ET)

Stroke, IschemicMechanical ThrombectomyIntravascular Thrombosis
Hui-Sheng Chen30 enrolled1 locationNCT04664933
Recruiting
Not Applicable

Results of the Use of Two Stentrievers Simultaneosly Compared With One as a Primary Treatment in Acute Ischemic Stroke

Arterial Occlusive DiseasesThrombectomyStroke
Fundación EPIC200 enrolled4 locationsNCT05930145
Recruiting

Prognostic Value of Isolated and Combined Score Aspects in Acute Ischemic Stroke

ThrombectomyStroke, IschemicMagnetic Resonance Imaging+4 more
Centre Hospitalier de Gonesse152 enrolled1 locationNCT07069452
Recruiting
Not Applicable

The EFFECT of FUNCTIONAL ELECTRICAL STIMULATING on PHYSICAL ACTIVITY and QUALITY of LIFE in PATIENTS with PARALIS AFTER THROMBECTOMY: a RANDOMIZED CONTROLLED STUDY

Thrombectomy
Cukurova University60 enrolled1 locationNCT05975697
Recruiting

Acute Ischemic Stroke EndoVascular Therapy: a Multicenter REGISTRY Study

ThrombectomyThrombosisAcute Ischemic Stroke+1 more
Changhai Hospital10,000 enrolled1 locationNCT05864638
Recruiting

Accelerating Referral for Thrombectomy in Acute Stroke Patients Using an Artificial Intelligence-based Software

ThrombectomyStrokeStroke, Acute+1 more
Hospital Universitari Vall d'Hebron Research Institute250 enrolled2 locationsNCT06741332
Recruiting
Not Applicable

A Multicenter, Randomized Controlled Clinical Investigation to Evaluate the Safety and Effectiveness of the Super-Bore 8/7F Aspiration Catheters in the Treatment of Acute Intracranial Large Vessel Occlusion

Acute Ischemic StrokeEndovascular Thrombectomy
The First Affiliated Hospital of University of Science and Technology of China360 enrolled1 locationNCT06559475
Recruiting
Not Applicable

Thrombectomy Versus Best Medical Management in Large Vessel Occlusion Stroke Patients Presenting Beyond 24 Hours and With Presence of Collateral Flow on CT Angiography

ThrombectomyStroke, AcuteMedical Treatment+1 more
Tianjin Huanhu Hospital350 enrolled1 locationNCT06654375
Recruiting
Not Applicable

AI-Driven CTA Reconstruction for Intracranial LVO

Artificial Intelligence (AI)Acute Ischemic StrokeCT Angiography+1 more
Shanghai Jiao Tong University Affiliated Sixth People's Hospital174 enrolled2 locationsNCT06645405
Recruiting
Not Applicable

Evaluation of Endovascular Treatment in Acute Intracranial Distal Medium Vessel Occlusion Stroke

Acute Ischemic StrokeEndovascular Thrombectomy
The First Affiliated Hospital of University of Science and Technology of China564 enrolled1 locationNCT06146790
Recruiting
Not Applicable

Effects of Post-Operative Sedation for Endovascular Thrombectomy

Acute Ischemic StrokeEndovascular Thrombectomy
RenJi Hospital1,286 enrolled1 locationNCT04517383
Recruiting
Not Applicable

Patient Selection Using MR With Non-Perfusion Imaging for Endovascular Treatment Within 6 to 24 Hours

Endovascular Thrombectomy
Tianjin Huanhu Hospital352 enrolled1 locationNCT05735301